abstract-dark-graphic-banner--3
April 7, 2026 | 11 AM ET

First-time launch data decisions

What to buy, what to rent, and when to do it

As emerging biopharma teams move from late Phase 2 into launch planning, data questions come quickly, often before commercial assumptions, field design, or access strategy are fully defined.

 

There’s no shortage of data or vendors. The challenge is knowing what’s essential, what can wait, when to purchase datasets versus rent analysis (and the underlying data), and how to extract maximum value from what you have before adding something new.

 

In this focused, practical session, Beghou’s Jenny Herritz and Todd Foster will draw on their experience helping emerging biopharma teams use data strategically to punch above their weight in competitive markets.

  • Decisions and timing: What questions drive data needs, including what to buy, what to rent, and how frequently data needs to be refreshed
  • Stakeholder alignment: How to align commercial, medical, access, analytics, and IT stakeholder needs before debating datasets

  • Market and vendor dynamics: What’s shifting in the landscape and how that will impact decisions going forward

  • Common missteps: Where teams overbuy, mis-sequence, or lock into infrastructure too early

  • Making the most of what you have: How to extract more insight from core datasets before investing to expand your footprint

  • Real-world application: Live Q&A on real first-launch scenarios

Turning investments into real patient impact: Lessons from consumer-oriented and specialty Rx brands

Patient centricity means very different things depending on the brand. For consumer-oriented products, it often shows up as reach, relevance, and sustained engagement at scale. For specialty and complex therapies, it’s about precision, access, and navigating a complex patient journey. Yet across both, teams are grappling with the same challenge: how to turn data, AI, and technology investments into real patient impact, without losing trust or cohesion along the way.

Speakers

Beghou0055 1e 1 1 edt2

Jenny Herritz

Partner, Beghou

Todd Foster_SQUARE. (2) (1)

Todd Foster

Associate Partner, Beghou